Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
Clinical trial NCT06908668 · RECRUITING
Trial details
- NCT number
- NCT06908668
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-31
- Primary completion
- 2028-09-10
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.